Insider transactions

EDGAR

OKYO Pharma Limited

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
7 transactions, 94,363 shares
Sum of shares × price per share: 136,005.87
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–19 of 19

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-07-27 Filed 2026-08-07Patil Rajkumar V. Officer: Chief Scientific Officer
P

Open market or private purchase of non-derivative or derivative security

COMMON STOCK
Acquired (A)3,3631.49
5,010.87

Derived: shares × price per share. Exact value 5010.87.

20,030Direct (D) No— Open filing 0001493152-26-036581 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-29Patil Rajkumar V. Officer: Chief Scientific Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

COMMON STOCK
Acquired (A)3,3631.49
5,010.87

Derived: shares × price per share. Exact value 5010.87.

20,030Direct (D) No— Open filing 0001493152-26-035212 Read from the filing’s XML Dispute this row
2026-07-22 Filed 2026-08-07Dempsey Robert John Director · Officer: CHIEF EXECUTIVE OFFICER
P

Open market or private purchase of non-derivative or derivative security

COMMON STOCK
Acquired (A)15,0001.539
23,085

Derived: shares × price per share. Exact value 23085.000.

15,000Direct (D) No— Open filing 0001493152-26-036584 Read from the filing’s XML Dispute this row
2026-07-22 Filed 2026-07-23Dempsey Robert John Director · Officer: CHIEF EXECUTIVE OFFICER
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

COMMON STOCK
Acquired (A)15,0001.539
23,085

Derived: shares × price per share. Exact value 23085.000.

15,000Direct (D) No— Open filing 0001493152-26-034409 Read from the filing’s XML Dispute this row
2026-07-21 Filed 2026-08-07BRANCACCIO JOHN P Director
P

Open market or private purchase of non-derivative or derivative security

COMMON STOCK
Acquired (A)5,0001.477
7,385

Derived: shares × price per share. Exact value 7385.000.

35,201Direct (D) No— Open filing 0001493152-26-036585 Read from the filing’s XML Dispute this row
2026-07-21 Filed 2026-08-07JACOB GARY S Director · Officer: CHIEF DEVELOPMENT OFFICER
P

Open market or private purchase of non-derivative or derivative security

COMMON STOCK
Acquired (A)3,5001.4
4,900

Derived: shares × price per share. Exact value 4900.0.

112,420Direct (D) No— Open filing 0001493152-26-036583 Read from the filing’s XML Dispute this row
2026-07-21 Filed 2026-08-07Mantelli Flavio Officer: CHIEF MEDICAL OFFICER
P

Open market or private purchase of non-derivative or derivative security

COMMON STOCK
Acquired (A)20,0001.4
28,000

Derived: shares × price per share. Exact value 28000.0.

20,000Direct (D) No— Open filing 0001493152-26-036580 Read from the filing’s XML Dispute this row
2026-07-21 Filed 2026-08-07CERRONE GABRIELE M Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

COMMON STOCK
Acquired (A)22,5001.45
32,625

Derived: shares × price per share. Exact value 32625.00.

10,873,916Indirect (I) Via Panetta Partners LimitedNo— Open filing 0001493152-26-036579 Read from the filing’s XML Dispute this row
2026-07-21 Filed 2026-07-23CERRONE GABRIELE M Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

COMMON STOCK
Acquired (A)22,5001.45
32,625

Derived: shares × price per share. Exact value 32625.00.

10,873,916Indirect (I) Via Panetta Partners LimitedNo— Open filing 0001493152-26-034408 Read from the filing’s XML Dispute this row
2026-07-21 Filed 2026-07-23JACOB GARY S Director · Officer: CHIEF DEVELOPMENT OFFICER
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

COMMON STOCK
Acquired (A)3,5001.40
4,900

Derived: shares × price per share. Exact value 4900.00.

112,420Direct (D) No— Open filing 0001493152-26-034406 Read from the filing’s XML Dispute this row
2026-07-21 Filed 2026-07-23BRANCACCIO JOHN P Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

COMMON STOCK
Acquired (A)5,0001.477
7,385

Derived: shares × price per share. Exact value 7385.000.

35,201Direct (D) No— Open filing 0001493152-26-034405 Read from the filing’s XML Dispute this row
2026-07-21 Filed 2026-07-22Mantelli Flavio Officer: CHIEF MEDICAL OFFICER
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

COMMON STOCK
Acquired (A)20,0001.40
28,000

Derived: shares × price per share. Exact value 28000.00.

20,000Direct (D) No— Open filing 0001493152-26-034236 Read from the filing’s XML Dispute this row
2026-07-20 Filed 2026-08-07CERRONE GABRIELE M Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

COMMON STOCK
Acquired (A)25,0001.4
35,000

Derived: shares × price per share. Exact value 35000.0.

10,851,416Indirect (I) Via Panetta Partners LimitedNo— Open filing 0001493152-26-036582 Read from the filing’s XML Dispute this row
2026-07-20 Filed 2026-07-21CERRONE GABRIELE M Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

COMMON STOCK
Acquired (A)25,0001.40
35,000

Derived: shares × price per share. Exact value 35000.00.

10,851,416Indirect (I) Via Panetta Partners LimitedNo— Open filing 0001493152-26-034084 Read from the filing’s XML Dispute this row
2026-06-08 Filed 2026-06-10Denoyer Bernard Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option — underlying Common Shares (3,500) — exercise price 1.85
Acquired (A)3,5001.85
6,475

Derived: shares × price per share. Exact value 6475.00.

35,190Direct (D) No— Open filing 0001493152-26-028134 Read from the filing’s XML Dispute this row
2026-06-08 Filed 2026-06-10CERRONE GABRIELE M Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

COMMON STOCK
Acquired (A)300,0001.72
516,000

Derived: shares × price per share. Exact value 516000.00.

10,826,416Indirect (I) Via Panetta Partners LimitedNo— Open filing 0001493152-26-028117 Read from the filing’s XML Dispute this row
2026-06-08 Filed 2026-06-10Simon Willy Jules Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option — underlying Common Shares (6,500) — exercise price 1.85
Acquired (A)6,5001.85
12,025

Derived: shares × price per share. Exact value 12025.00.

135,502Direct (D) No— Open filing 0001493152-26-028132 Read from the filing’s XML Dispute this row
2026-06-08 Filed 2026-06-10BRANCACCIO JOHN P Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option — underlying Common Shares (6,500) — exercise price 1.85
Acquired (A)6,5001.85
12,025

Derived: shares × price per share. Exact value 12025.00.

138,394Direct (D) No— Open filing 0001493152-26-028133 Read from the filing’s XML Dispute this row
2026-06-08 Filed 2026-06-10Shah Keeren Rameshchandra Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option — underlying Common Shares (40,000) — exercise price 1.85
Acquired (A)40,0001.85
74,000

Derived: shares × price per share. Exact value 74000.00.

544,819Direct (D) No— Open filing 0001493152-26-028131 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.

Showing 1–19 of 19

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Woodline Partners LP 3,653,531 SH4,713,055 dollarsHigher by 763 Prior quarter: 3,652,768Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
Opaleye Management Inc. 1,620,000 SH2,089,800 dollarsHigher by 1,244,796 Prior quarter: 375,204Open filing 0001420506-26-002880 Filed 2026-11-16 Dispute this row
Stonepine Capital Management, LLC 914,367 SH1,179,533 dollarsHigher by 51,371 Prior quarter: 862,996Open filing 0001440771-26-000027 Filed 2026-11-13 Dispute this row
Balyasny Asset Management L.P. 680,941 SH878,414 dollarsHigher by 100,345 Prior quarter: 580,596Open filing 0001193125-26-463223 Filed 2026-11-16 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager36,964 SH47,684 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
XTX Topco Ltd Partly reported under another manager33,527 SH43,250 dollarsLower by 4,242 Prior quarter: 37,769Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row
CHOREO, LLC 33,255 SH42,899 dollarsUnchanged Prior quarter: 33,255Open filing 0001214659-26-013321 Filed 2026-10-28 Dispute this row
Quantinno Capital Management LP 33,255 SH42,899 dollarsUnchanged Prior quarter: 33,255Open filing 0001759654-26-000011 Filed 2026-11-13 Dispute this row
Cerity Partners LLC 12,812 SH16,527 dollarsUnchanged Prior quarter: 12,812Open filing 0001172661-26-005020 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC 12,090 SH15,596 dollarsUnchanged Prior quarter: 12,090Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
HRT FINANCIAL LP 11,520 SH14 dollarsNot in the prior quarter’s filings read Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
Steward Partners Investment Advisory, LLC 6,000 SH7,740 dollarsUnchanged Prior quarter: 6,000Open filing 0001723397-26-000006 Filed 2026-11-13 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager1,480 SH2,013 dollarsNot in the prior quarter’s filings read Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
Allworth Financial LP 1,000 SH1,290 dollarsNot in the prior quarter’s filings read Open filing 0001140361-26-044466 Filed 2026-11-17 Dispute this row
EFG International AG Partly reported under another manager923 SH1,191 dollarsUnchanged Prior quarter: 923Open filing 0002109868-26-000012 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager346 SH446 dollarsLower by 54,663 Prior quarter: 55,009Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Continuum Advisory, LLC 50 SH65 dollarsUnchanged Prior quarter: 50Open filing 0001420506-26-002682 Filed 2026-11-13 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager23 SH30 dollarsNot in the prior quarter’s filings read Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
Caitong International Asset Management Co., Ltd 1 SH1 dollarsLower by 2 Prior quarter: 3Open filing 0001628280-26-068135 Filed 2026-10-29 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Maven Securities LTD 809,317 SH
  • RENAISSANCE TECHNOLOGIES LLC 11,200 SH
  • JANE STREET GROUP, LLC 10,302 SH
  • OSAIC HOLDINGS, INC. 152 SH
  • MORGAN STANLEY 10 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Sirenia Capital Management LP Ordinary Shares, without par value7.74,054,054.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0000919574-26-003208 Dispute this row
Alex Silverstein Ordinary Shares, without par value7.74,054,054.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0000919574-26-003208 Dispute this row
Woodline Partners LP Ordinary Shares, no par value7.03,652,190.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0000919574-26-003227 Dispute this row
Point72 Asset Management, L.P. Ordinary Shares, no par value00.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-003508 Dispute this row
Point72 Capital Advisors, Inc. Ordinary Shares, no par value00.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-003508 Dispute this row
Steven A. Cohen Ordinary Shares, no par value00.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-003508 Dispute this row
Point72 Asset Management, L.P. Ordinary Shares, no par value7.94,058,445.0002/17/2026 Filed 2026-02-18SCHEDULE 13GOpen filing 0000902664-26-001188 Dispute this row
Point72 Capital Advisors, Inc. Ordinary Shares, no par value7.94,058,445.0002/17/2026 Filed 2026-02-18SCHEDULE 13GOpen filing 0000902664-26-001188 Dispute this row
Steven A. Cohen Ordinary Shares, no par value7.94,058,445.0002/17/2026 Filed 2026-02-18SCHEDULE 13GOpen filing 0000902664-26-001188 Dispute this row
Chernett Jorey Common9.53,802,194.0012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 2Open filing 0002042077-26-000017 Dispute this row
Dauntless Investment Group, LLC Common1.2471,523.0012/31/2025 Filed 2026-02-12SCHEDULE 13G/AAmendment 3Open filing 0002044285-26-000005 Dispute this row
Chernett Jorey Common7.82,984,862.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0002042077-25-000008 Dispute this row
Dauntless Investment Group, LLC Common6.32,422,048.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0002044285-25-000014 Dispute this row
LAURA NATALIA MONICA FONDA Common5.011,928,451.0007/22/2025 Filed 2025-10-29SCHEDULE 13GOpen filing 0001493152-25-019998 Dispute this row
Dauntless Investment Group, LLC Common7.32,735,780.0006/30/2025 Filed 2025-08-05SCHEDULE 13G/AAmendment 1Open filing 0001137439-25-000996 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,550,114 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020176,407
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,403

Filings made before the SEC required XML are listed, not extracted.

Back to OKYO Pharma Limited